|

UK gov asked MHRA regulator to assess Oxford/Astrazeneca covid-19 vaccine for temporary supply

Reuters has reported that Britain on Friday asked its medicine regulator to assess Oxford University and AstraZeneca's AZN.L COVID-19 vaccine candidate for temporary supply, a step towards beginning a roll-out before the end of the year.

''AstraZeneca expects 4 million doses to be available in Britain by the end of next month, and health minister Hancock is targeting the roll-out to begin before Christmas,'' Reuters wrote.

"We have formally asked the regulator to assess the Oxford/AstraZeneca vaccine, to understand the data and determine whether it meets rigorous safety standards," Hancock said in a statement, reported by Reuters. 

"This letter is an important step towards deploying a vaccine as quickly as safely possible."

More key notes

''Britain's Medicines and Healthcare products Regulatory Agency (MHRA) is already assessing the vaccine in a "rolling review" as data comes in on safety and efficacy.''

''Hancock has also asked the MHRA to approve the Pfizer/BioNTech candidate after it was shown to be 95% effective.''

''Oxford and AstraZeneca AZN.L published interim efficacy results on Monday, which showed that the vaccine could be 90% effective when given as a half dose followed by a full dose.''

''Questions have been raised about the Oxford/AstraZeneca data and the robustness of that result, though the MHRA approved the use of the half-dose/full-dose regime a subgroup received in the trial.''

''Britain's top science adviser said on Thursday that the interim results showed the Oxford/AstraZeneca vaccine worked.''

Market implications

The pound is already solid on the prospects of a Brexit breakthrough and a faster economic recovery pertaining to a vaccine. 

Author

Ross J Burland

Ross J Burland, born in England, UK, is a sportsman at heart. He played Rugby and Judo for his county, Kent and the South East of England Rugby team.

More from Ross J Burland
Share:

Editor's Picks

EUR/USD keeps the offered stance just above 1.1700

EUR/USD is coming under heavy selling pressure in what has been a rather grim start to the new trading week, with the pair now trading close to the 1.1700 support area as the US Dollar stages a solid rebound. The prevailing flight to safety mood continues to favour the Greenback, as investors react to the escalating conflict in the Middle East and trim risk exposure across the board.

GBP/USD hits new yearly lows near 1.3300

GBP/USD adds to the recent bearish tone, approaching to the key 1.3300 support to reach fresh YTD troughs against the backdrop of the robust performance of the US Dollar. Indeed, Cable’s decline comes amid the firm demand for the safe-haven space in the wake of the US and Israel attacks to Iran.

Gold battles to retain the positive momentum

Gold now surrenders part of the earlier advance past the $5,400 mark per troy ounce at the beginning of the week. Indeed, the precious metal’s strong uptick remains fuelled by increasing geopolitical tensions in the Middle East amid the intense demand for safer assets.

Bitcoin on brink of breakdown amid US-Iran war

Bitcoin (BTC) remains under pressure near the key support level of $65,700. Trading at $66,400 at the time of writing on Monday, a breakdown below this critical level would suggest a deeper correction ahead.

The Fed is finally talking about AI – Here's why it matters for the US Dollar

AI is moving from earnings calls into the heart of monetary policy discussions, forcing Federal Reserve officials to confront a new question: How to act if AI reshapes inflation, employment and interest rates at the same time?

Grass 20% bullish breakout defies broader market weakness

Grass (GRASS) is edging up above $0.30 at the time of writing on Monday. The token’s notable 20% intraday surge stands out amid heightened volatility in the broader crypto market.